InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Cruse Michael, Vice-Président Senior. Officer active across 1 companies, notably Reneo Pharmaceuticals, Inc.. In total, 4 reports have been recorded. Total volume traded: €32k. The latest transaction was filed on 10 December 2021 — Attribution. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations4 total
025,000 shares0
Common Stock
SEC:0001209191-21-069436·
025,000 shares0
Common Stock
SEC:0001209191-21-069436:0·
€15,8112,500 shares@ €6.3242100.0% of flow
Common Stock
SEC:0001209191-21-053520·
Ideal exit: 22 May 2022 (T+270)
€15,8112,500 shares@ €6.324250.0% of flow
Common Stock
SEC:0001209191-21-053520:0·
Ideal exit: 22 May 2022 (T+270)
4 of 4 declarations
About Cruse Michael
Cruse Michael is the Senior Vice President of Corporate Operations at Reneo Pharmaceuticals, Inc. He is responsible for managing operations and optimizing processes within the company. His role is essential to ensure that Reneo achieves its strategic and operational objectives while maintaining a high level of quality in its services.
